SEARCH

SEARCH BY CITATION

References

  • 1
    The Act of July 2, 1999 No. 63 relating to Patients’ Rights (the Patients’ Rights Act) Lov 2. Juli 1999 nr. 63 om pasientrettigheter (pasientrettighetsloven) Norges Lover 1687–2003. Gyldendal Akade-misk: Oslo, Norway, 2004.
  • 2
    Office for National Statistics. 2004. Available: http://www.ssb.no/emner/03/01/20/abort.
  • 3
    Grimes DA, Schulz KF, Cates Jr WJ. Prevention of uterine perforation during curettage abortion. JAMA 1984;251: 21082111.
  • 4
    Schulz KF, Grimes DA, Cates W. Measures to prevent cervical injury during suction curettage abortion. Lancet 1983;i: 11821184.
  • 5
    Blanchard K, Clark S, Winikoff B, Gaines G, Kabani G, Shannon C. Misoprostol for women's health. Obstet Gynecol 2002;99(2):316332.
  • 6
    Chuck FJ, Huffaker BJ. Labor induction with intravaginal misoprostol versus intracervical prostaglandin E2 gel (Prepidil gel): a randomized comparison. Am J Obstet Gynecol 1995;173: 11371142.
  • 7
    Darney PD. Misoprostol: a boon to safe motherhood … or not? Lancet 2001;358: 682.
  • 8
    Ngai SW, Tang OS, Lao T, Ho PC. Oral misoprostol versus placebo for cervical dilatation prior to vacuum aspiration in first trimester pregnancy. Hum Reprod 1995;10: 12201222.
  • 9
    Ngai SW, Yeung KC, Lao T, Ho PC. Oral misoprostol versus vaginal gemeprost for cervical dilatation prior to vacuum aspiration in women in the sixth to twelfth week of gestation. Contraception 1995;51: 347350.
  • 10
    Oppegaard KS, Abdelnoor M, Nesheim BI, Jerve F, Eskild A. The use of oral misoprostol for pre-abortion cervical priming: a randomised controlled trial of 400 μg versus 200 μg in first trimester pregnancies. BJOG 2004;111: 154159.
  • 11
    CONSORT Group. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357: 11911194.
  • 12
    Dallal G. Available: http://www.randomization.com.
  • 13
    Zieman M, Fong SK, Benowitz NL, Banskten D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90: 8892.
  • 14
    Singh K, Fong YF, Prasad RN, Ding F. Does an acidic medium enhance the efficacy of vaginal misoprostol for pre-abortion cervical priming? Hum Reprod 1999;14: 16351637.
  • 15
    Ngai SW, Chan YM, Ho PC. The use of misoprostol for pre-operative cervical dilatation prior to vacuum aspiration: a randomized trial. Hum Reprod 1999;14(8):21392142.
  • 16
    De Jonge ET, Jewkes R, Levin J, Rees H. Randomised controlled trial of the efficacy of misoprostol used as a cervical ripening agent prior to termination of pregnancy in the first trimester. S Afr Med J 2000;90(3):256262.
  • 17
    El-Refaey H, Rajasekar D, Abdalla M, Calder L, Tempelton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995;332: 983987.
  • 18
    El-Refaey H, Calder I, Wheatley DN, Templeton A. Cervical priming with prostaglandin E1 analogues, misoprostol and gemeprost. Lancet 1994;343: 12071209.
  • 19
    Lawrie A, Penney G, Templeton AA. A randomised comparison of oral and vaginal misoprostol for cervical priming before suction termination of pregnancy. Br J Obstet Gynaecol 1996;103: 11171119.
  • 20
    Singh K, Fong YF, Prasad NV, Dong F. Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming. Obstet Gynecol 1998;92(5):795798.
  • 21
    Macisaac L, Grossman D, Balistreri E, Darney P. A randomized controlled trial of laminaria, oral misoprostol, and vaginal misoprostol before abortion. Obstet Gynecol 1999;93(5):766770.
  • 22
    Singh K, Fong YF, Prasad NV, Dong F. Vaginal misoprostol for pre-abortion cervical priming: is there an optimal evacuation time interval? Br J Obstet Gynaecol 1999;106: 266269.
  • 23
    Ashok PW, Hamoda H, Nathani F, Flett GM, Templeton A. Randomised controlled study comparing oral and vaginal misoprostol for cervical priming prior to surgical termination of pregnancy. BJOG 2003;110: 10571061.
  • 24
    Goldberg AB, Mara B, Greenberg BS, Darney PD. Misoprostol and pregnancy. N Engl J Med 2001;344(1):3860.
  • 25
    Fong YF, Singh K, Prasad RN. A comparative study using two dose regimens (200 μg or 400 μg) of vaginal misoprostol for pre-operative cervical dilatation in first trimester nulliparae. Br J Obstet Gynaecol 1998;105: 413417.
  • 26
    Singh K, Fong YF, Prasad RN, Dong F. Evacuation interval after vaginal misoprostol for preabortion cervical priming: a randomized trial. Obstet Gynaecol 1999;94: 431434.
  • 27
    Ngai SW, Yeung KC, Lao T, Ho PC. Oral misoprostol versus mife-pristone for cervical dilatation before vacuum aspiration in first trimester nulliparous pregnancy: a double blind prospective randomised study. Br J Obstet Gynaecol 1996;103: 11201123.
  • 28
    Eskild A, Helgadottir LB, Jerve F, Qvigstad E, Pedersen SS, Løset Å. Induced abortion among non-Western immigrant women in Oslo, Norway. Tidsskr Nor Lægeforen 2002;122: 13551357.
  • 29
  • 30
    Alexander NJ, Baker E, Kaptein M, Karck U, Miller L, Zampaglione E. Why consider vaginal drug administration? Fertil Steril 2004;82: 112.
  • 31
    Aronsson A, Bygdeman M, Gemzell-Danielsson. Effects of misoprostol on uterine contractility following different routes of administration. Hum Reprod 2004;19: 8184.
  • 32
    Hamoda H, Ashok PW, Flett GM, Templeton A. A randomized controlled comparison of sublingual and vaginal administration of miso-prostol for cervical priming before first-trimester surgical abortion. Am J Obstet Gynecol 2004;190: 5559.
  • 33
    Aubeny E, Chatellier G. A randomized comparison of mifepristone and self-administered oral or vaginal misoprostol for early abortion. Eur J Contracept Reprod Health Care 2000;5: 171176.
  • 34
    Tang OS, Mok KH, Ho PC. A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester. Hum Reprod 2004;19: 11011104.
  • 35
    Vimala N, Mittal S, Kumar S, Dadhwal V, Sharma Y. A randomized comparison of sublingual and vaginal misoprostol for cervical priming before suction termination of first-trimester pregnancy. Contraception 2004;70: 117120.
  • 36
    Saxena P, Salhan S, Sarda N. Comparison between the sublingual and oral route of misoprostol for pre-abortion cervical priming in first trimester abortions. Hum Reprod 2004;19: 7780.
  • 37
    Kiran U, Amin P, Penketh RJ. Self-administration of misoprostol for termination of pregnancy: safety and efficacy. J Obstet Gynaecol 2004;24: 155156.
  • 38
    Guengent JP, Bangou J, Elul B, Ellertson C. Mifepristione-misoprostol medical abortion: home administration of misoprostol in Guadeloupe. Contraception 1999;60: 167172.
  • 39
    Schaff EA, Stadalius LS, Eisinger SH, Franks P. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract 1997;44: 353360 (April).
  • 40
    Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 1999;59: 16.
  • 41
    Carbonell JL, Varela L, Velazco A, Tanda R, Sanchez C. Vaginal misoprostol for abortion at 10–13 weeks’ gestation. Eur J Contracept Reprod Health Care 1999;4: 3540.
  • 42
    Elul B, Pearlman E, Sorhaindo A, Simonds W, Westhoff C. In-depth interviews with medical abortion clients: thoughts on the method and home administration of misoprostol. J Am Med Women's Assoc 2000;55: 169172.
  • 43
    Sharma S, El Refaey H, Stafford M, Purkayastha S, Parry M, Axby H. Oral versus vaginal misoprostol administered one hour before surgical termination of pregnancy: a randomised controlled trial. BJOG 2005;112: 456460.